Causal modeling of CALGB 80405 (Alliance) to identify network drivers of metastatic colorectal cancer (CRC).

Rahul K Das,Leon Furchtgott,Jeffrey A. Meyerhardt,Andrew B. Nixon,Federico Innocenti,D. R. da Cunha,Kelly Rich,Heinz-Josef Lenz,Donna Niedzwiecki,Eileen Mary OReilly,Fang Shu Ou,Jeanne C. Latourelle,Diane Wuest,Boris Hayete,Iya Khalil,Alan P. Venook

Causal modeling of CALGB 80405 (Alliance) to identify network drivers of metastatic colorectal cancer (CRC).

2018

Rahul K Das
Leon Furchtgott
Jeffrey A. Meyerhardt
Andrew B. Nixon
Federico Innocenti
D. R. da Cunha
Kelly Rich
Heinz-Josef Lenz
Donna Niedzwiecki
Eileen Mary OReilly
Fang Shu Ou
Jeanne C. Latourelle
Diane Wuest
Boris Hayete
Iya Khalil
Alan P. Venook

3570Background: CALGB 80405 is a phase III clinical trial of FOLFOX/ FOLFIRI with randomly assigned cetuximab/ bevacizumab. Novel causal machine learning approaches to the study dataset may lead to...

Keywords:

Causal model
Alliance
Physical therapy
Colorectal cancer
Cancer research
Medicine
Bevacizumab
Cetuximab
Oncology
Clinical trial
FOLFIRI
Internal medicine
FOLFOX

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations